bpc-157 safety fda warning compounded peptide Compounded "semaglutide" is not FDA-approved bpc-157 safety fda warning BPC-157:

Platelet-rich plasma or extracorporeal shockwave therapy for plantar fasciitis

GLP-Squared Injection starts at $249 per month, with pricing flat across all dose levels

The pH of the reconstituted product ranges from 3.5 to 6.0

For researchers, TB-500 offers: A well-characterized active fragment of Thymosin Beta-4 Published preclinical data on wound healing, cardiac repair, and cell migration Complementary mechanism to BPC-157 for combination research Availability for laboratory and investigational protocols For comprehensive information on which peptides have FDA approval, see our FDA Approved Peptides List 2026 guide